We are live on ! Find out more
IIM

Ipswich Investment Management Portfolio holdings

AUM $474M
1-Year Est. Return 35.58%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+35.58%
3 Year Est. Return
+92.81%
5 Year Est. Return
+126.14%
10 Year Est. Return
+1,334%
AUM
$236M
AUM Growth
+$13.5M
Cap. Flow
-$113K
Cap. Flow %
-0.05%
Top 10 Hldgs %
28.95%
Holding
152
New
10
Increased
24
Reduced
68
Closed
2

Top Buys

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$2.86M
2
PX
Praxair Inc
PX
+$1.4M
3
IWV icon
iShares Russell 3000 ETF
IWV
+$967K
4
CRSP icon
CRISPR Therapeutics
CRSP
+$917K
5
DD icon
DuPont de Nemours
DD
+$755K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$1.21M
2
MAR icon
Marriott International
MAR
+$1.11M
3
SLB icon
SLB Ltd
SLB
+$1.07M
4
CELG
Celgene Corp
CELG
+$980K
5
IJJ icon
iShares S&P Mid-Cap 400 Value ETF
IJJ
+$904K

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Technology 14.83%
3 Energy 14.12%
4 Financials 12.42%
5 Industrials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
26
Procter & Gamble
PG
$339B
$2.86M 1.21%
31,079
-20
-0.1% -$1.8K
BNS icon
27
Scotiabank
BNS
$108B
$2.85M 1.21%
+44,221
New +$2.86M
MRK icon
28
Merck
MRK
$318B
$2.71M 1.15%
50,448
– –
PX
29
DELISTED
Praxair Inc
PX
$2.34M 0.99%
15,138
+9,438
+166% +$1.4M
CHD icon
30
Church & Dwight Co
CHD
$24.5B
$2.33M 0.99%
46,516
-1,309
-3% -$61.4K
LH icon
31
Labcorp
LH
$25.9B
$2.33M 0.99%
16,985
+303
+2% +$40K
ORCL icon
32
Oracle
ORCL
$423B
$2.32M 0.98%
49,072
+730
+2% +$35.8K
CL icon
33
Colgate-Palmolive
CL
$74.4B
$2.28M 0.97%
30,220
-574
-2% -$41.9K
DUK icon
34
Duke Energy
DUK
$97.3B
$2.25M 0.95%
26,804
-214
-0.8% -$18.7K
MRSH
35
Marsh
MRSH
$91.5B
$2.24M 0.95%
27,535
+1,835
+7% +$153K
PEP icon
36
PepsiCo
PEP
$190B
$2.24M 0.95%
18,652
– –
TFC icon
37
Truist Financial
TFC
$64B
$2.18M 0.92%
43,760
-2,125
-5% -$103K
MCD icon
38
McDonald's
MCD
$195B
$1.97M 0.83%
11,433
-32
-0.3% -$5.37K
BIIB icon
39
Biogen
BIIB
$30.7B
$1.89M 0.8%
5,936
+346
+6% +$111K
NVS icon
40
Novartis
NVS
$297B
$1.88M 0.8%
24,985
– –
CELG
41
DELISTED
Celgene Corp
CELG
$1.86M 0.79%
17,788
-8,685
-33% -$980K
T icon
42
AT&T
T
$163B
$1.82M 0.77%
61,923
+186
+0.3% +$5.08K
GE icon
43
GE Aerospace
GE
$384B
$1.79M 0.76%
21,417
-6,560
-23% -$626K
BMY icon
44
Bristol-Myers Squibb
BMY
$132B
$1.75M 0.74%
28,617
– –
RCL icon
45
Royal Caribbean
RCL
$85.6B
$1.66M 0.7%
13,894
+125
+0.9% +$15.5K
KO icon
46
Coca-Cola
KO
$375B
$1.62M 0.69%
35,325
-60
-0.2% -$2.76K
TMO icon
47
Thermo Fisher Scientific
TMO
$220B
$1.52M 0.64%
7,990
+30
+0.4% +$5.75K
VZ icon
48
Verizon
VZ
$196B
$1.46M 0.62%
27,610
-75
-0.3% -$3.69K
AKAM icon
49
Akamai
AKAM
$15.9B
$1.43M 0.61%
22,024
+155
+0.7% +$8.58K
TTE icon
50
TotalEnergies
TTE
$190B
$1.39M 0.59%
2,306,568
-26,113
-1% -$15.6K
1
2
3 4 5

Similar funds

KC
Keenan Capital Burlingame, California $474M AUM 2.41% 1-Year Est. Return
PCM
Pamplona Capital Management New York $473M AUM 3.78% 1-Year Est. Return
CCM
CoreView Capital Management Hong Kong $473M AUM 14.25% 1-Year Est. Return
CTWM
Cherry Tree Wealth Management Minnetonka, Minnesota $473M AUM 12.37% 1-Year Est. Return
RCM
Rivermont Capital Management New York $475M AUM 116.05% 1-Year Est. Return
MCA
MSH Capital Advisors Scottsdale, Arizona $472M AUM 16.23% 1-Year Est. Return
BSI
Bregal Sagemount IV St. Helier $472M AUM
SIA
Sovereign Investment Advisors Phoenix, Arizona $472M AUM 9.63% 1-Year Est. Return

Ipswich Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Ipswich Investment Management held 152 positions worth $236M, up 6.1% from $223M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ipswich Investment Management's Q4 2017 filing shows 10 new, 24 increased, 68 reduced and 2 closed positions. Its largest new stake was Scotiabank: 44,221 shares worth $2.85M. The largest sale was T. Rowe Price, an estimated $1.21M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Energy.

  • Ipswich Investment Management's largest Q4 2017 buy was Scotiabank: 44,221 shares worth $2.85M.
  • Ipswich Investment Management added most to Praxair Inc in Q4 2017, an estimated $1.4M increase.
  • Ipswich Investment Management's biggest Q4 2017 reduction was T. Rowe Price, cutting an estimated $1.21M.
  • Ipswich Investment Management fully exited iShares S&P Mid-Cap 400 Value ETF in Q4 2017, selling an estimated $904K.
  • Ipswich Investment Management's ten largest holdings make up 29% of its $236M portfolio in Q4 2017.
  • Ipswich Investment Management opened 10 new positions and closed 2 in Q4 2017.
  • Ipswich Investment Management's portfolio value rose 6.1% quarter-over-quarter to $236M.

Based on Ipswich Investment Management's 13F filing for Q4 2017, filed 16 Jan 2018.